nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Doxorubicin—liver cancer	0.218	0.64	CbGbCtD
Bosentan—ABCB11—bile canaliculus—liver cancer	0.149	0.622	CbGeAlD
Bosentan—CYP2C9—Sorafenib—liver cancer	0.0636	0.186	CbGbCtD
Bosentan—ABCB11—bile duct—liver cancer	0.0464	0.194	CbGeAlD
Bosentan—CYP3A4—Sorafenib—liver cancer	0.037	0.108	CbGbCtD
Bosentan—ABCB11—bile—liver cancer	0.0357	0.149	CbGeAlD
Bosentan—CYP3A4—Doxorubicin—liver cancer	0.0224	0.0657	CbGbCtD
Bosentan—EDNRB—liver—liver cancer	0.00359	0.015	CbGeAlD
Bosentan—ABCB11—liver—liver cancer	0.0029	0.0122	CbGeAlD
Bosentan—CYP2C9—liver—liver cancer	0.000983	0.00412	CbGeAlD
Bosentan—CYP3A4—liver—liver cancer	0.00075	0.00314	CbGeAlD
Bosentan—Gastrointestinal pain—Sorafenib—liver cancer	0.000618	0.00265	CcSEcCtD
Bosentan—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000605	0.0026	CcSEcCtD
Bosentan—Hepatic function abnormal—Doxorubicin—liver cancer	0.000602	0.00258	CcSEcCtD
Bosentan—Urticaria—Sorafenib—liver cancer	0.000601	0.00258	CcSEcCtD
Bosentan—Abdominal pain—Sorafenib—liver cancer	0.000598	0.00257	CcSEcCtD
Bosentan—Body temperature increased—Sorafenib—liver cancer	0.000598	0.00257	CcSEcCtD
Bosentan—Renal impairment—Epirubicin—liver cancer	0.000598	0.00256	CcSEcCtD
Bosentan—Hepatic failure—Doxorubicin—liver cancer	0.000586	0.00251	CcSEcCtD
Bosentan—Eczema—Doxorubicin—liver cancer	0.000586	0.00251	CcSEcCtD
Bosentan—Cardiac failure—Epirubicin—liver cancer	0.000583	0.0025	CcSEcCtD
Bosentan—Hypoglycaemia—Epirubicin—liver cancer	0.000583	0.0025	CcSEcCtD
Bosentan—Cerebrovascular accident—Epirubicin—liver cancer	0.00058	0.00249	CcSEcCtD
Bosentan—Lethargy—Epirubicin—liver cancer	0.00058	0.00249	CcSEcCtD
Bosentan—Hyponatraemia—Epirubicin—liver cancer	0.000571	0.00245	CcSEcCtD
Bosentan—Pain in extremity—Epirubicin—liver cancer	0.000569	0.00244	CcSEcCtD
Bosentan—Affect lability—Epirubicin—liver cancer	0.00056	0.0024	CcSEcCtD
Bosentan—Hypersensitivity—Sorafenib—liver cancer	0.000557	0.00239	CcSEcCtD
Bosentan—Renal impairment—Doxorubicin—liver cancer	0.000553	0.00237	CcSEcCtD
Bosentan—Asthenia—Sorafenib—liver cancer	0.000543	0.00233	CcSEcCtD
Bosentan—Cardiac arrest—Epirubicin—liver cancer	0.000541	0.00232	CcSEcCtD
Bosentan—Hypoglycaemia—Doxorubicin—liver cancer	0.000539	0.00231	CcSEcCtD
Bosentan—Cardiac failure—Doxorubicin—liver cancer	0.000539	0.00231	CcSEcCtD
Bosentan—Mood swings—Epirubicin—liver cancer	0.000539	0.00231	CcSEcCtD
Bosentan—Cerebrovascular accident—Doxorubicin—liver cancer	0.000537	0.0023	CcSEcCtD
Bosentan—Lethargy—Doxorubicin—liver cancer	0.000537	0.0023	CcSEcCtD
Bosentan—Pruritus—Sorafenib—liver cancer	0.000535	0.0023	CcSEcCtD
Bosentan—Dehydration—Epirubicin—liver cancer	0.000529	0.00227	CcSEcCtD
Bosentan—Hyponatraemia—Doxorubicin—liver cancer	0.000528	0.00227	CcSEcCtD
Bosentan—Pain in extremity—Doxorubicin—liver cancer	0.000526	0.00226	CcSEcCtD
Bosentan—Liver function test abnormal—Epirubicin—liver cancer	0.000525	0.00225	CcSEcCtD
Bosentan—Dry skin—Epirubicin—liver cancer	0.000521	0.00224	CcSEcCtD
Bosentan—Orthostatic hypotension—Epirubicin—liver cancer	0.000519	0.00223	CcSEcCtD
Bosentan—Abdominal pain upper—Epirubicin—liver cancer	0.000519	0.00223	CcSEcCtD
Bosentan—Affect lability—Doxorubicin—liver cancer	0.000518	0.00222	CcSEcCtD
Bosentan—Hypokalaemia—Epirubicin—liver cancer	0.000518	0.00222	CcSEcCtD
Bosentan—Diarrhoea—Sorafenib—liver cancer	0.000517	0.00222	CcSEcCtD
Bosentan—Nasopharyngitis—Epirubicin—liver cancer	0.000509	0.00218	CcSEcCtD
Bosentan—Cardiac arrest—Doxorubicin—liver cancer	0.0005	0.00215	CcSEcCtD
Bosentan—Dizziness—Sorafenib—liver cancer	0.0005	0.00215	CcSEcCtD
Bosentan—Mood swings—Doxorubicin—liver cancer	0.000498	0.00214	CcSEcCtD
Bosentan—Abdominal distension—Epirubicin—liver cancer	0.000495	0.00212	CcSEcCtD
Bosentan—Asthma—Epirubicin—liver cancer	0.000492	0.00211	CcSEcCtD
Bosentan—Influenza—Epirubicin—liver cancer	0.000492	0.00211	CcSEcCtD
Bosentan—Dehydration—Doxorubicin—liver cancer	0.000489	0.0021	CcSEcCtD
Bosentan—Eosinophilia—Epirubicin—liver cancer	0.000487	0.00209	CcSEcCtD
Bosentan—Liver function test abnormal—Doxorubicin—liver cancer	0.000486	0.00208	CcSEcCtD
Bosentan—Dry skin—Doxorubicin—liver cancer	0.000482	0.00207	CcSEcCtD
Bosentan—Vomiting—Sorafenib—liver cancer	0.000481	0.00206	CcSEcCtD
Bosentan—Orthostatic hypotension—Doxorubicin—liver cancer	0.000481	0.00206	CcSEcCtD
Bosentan—Abdominal pain upper—Doxorubicin—liver cancer	0.000481	0.00206	CcSEcCtD
Bosentan—Hypokalaemia—Doxorubicin—liver cancer	0.000479	0.00206	CcSEcCtD
Bosentan—Angina pectoris—Epirubicin—liver cancer	0.000479	0.00205	CcSEcCtD
Bosentan—Rash—Sorafenib—liver cancer	0.000477	0.00205	CcSEcCtD
Bosentan—Dermatitis—Sorafenib—liver cancer	0.000476	0.00204	CcSEcCtD
Bosentan—Headache—Sorafenib—liver cancer	0.000474	0.00203	CcSEcCtD
Bosentan—Bronchitis—Epirubicin—liver cancer	0.000473	0.00203	CcSEcCtD
Bosentan—Nasopharyngitis—Doxorubicin—liver cancer	0.000471	0.00202	CcSEcCtD
Bosentan—Neutropenia—Epirubicin—liver cancer	0.00046	0.00197	CcSEcCtD
Bosentan—Dysuria—Epirubicin—liver cancer	0.00046	0.00197	CcSEcCtD
Bosentan—Abdominal distension—Doxorubicin—liver cancer	0.000458	0.00196	CcSEcCtD
Bosentan—Upper respiratory tract infection—Epirubicin—liver cancer	0.000457	0.00196	CcSEcCtD
Bosentan—Influenza—Doxorubicin—liver cancer	0.000455	0.00195	CcSEcCtD
Bosentan—Asthma—Doxorubicin—liver cancer	0.000455	0.00195	CcSEcCtD
Bosentan—Pollakiuria—Epirubicin—liver cancer	0.000454	0.00195	CcSEcCtD
Bosentan—Eosinophilia—Doxorubicin—liver cancer	0.00045	0.00193	CcSEcCtD
Bosentan—Nausea—Sorafenib—liver cancer	0.000449	0.00193	CcSEcCtD
Bosentan—Weight increased—Epirubicin—liver cancer	0.000447	0.00192	CcSEcCtD
Bosentan—Weight decreased—Epirubicin—liver cancer	0.000445	0.00191	CcSEcCtD
Bosentan—Hyperglycaemia—Epirubicin—liver cancer	0.000443	0.0019	CcSEcCtD
Bosentan—Angina pectoris—Doxorubicin—liver cancer	0.000443	0.0019	CcSEcCtD
Bosentan—Pneumonia—Epirubicin—liver cancer	0.000441	0.00189	CcSEcCtD
Bosentan—Infestation—Epirubicin—liver cancer	0.000438	0.00188	CcSEcCtD
Bosentan—Infestation NOS—Epirubicin—liver cancer	0.000438	0.00188	CcSEcCtD
Bosentan—Bronchitis—Doxorubicin—liver cancer	0.000437	0.00188	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000434	0.00186	CcSEcCtD
Bosentan—Renal failure—Epirubicin—liver cancer	0.000431	0.00185	CcSEcCtD
Bosentan—Stomatitis—Epirubicin—liver cancer	0.000427	0.00183	CcSEcCtD
Bosentan—Jaundice—Epirubicin—liver cancer	0.000427	0.00183	CcSEcCtD
Bosentan—Urinary tract infection—Epirubicin—liver cancer	0.000426	0.00183	CcSEcCtD
Bosentan—Conjunctivitis—Epirubicin—liver cancer	0.000426	0.00183	CcSEcCtD
Bosentan—Neutropenia—Doxorubicin—liver cancer	0.000425	0.00183	CcSEcCtD
Bosentan—Dysuria—Doxorubicin—liver cancer	0.000425	0.00183	CcSEcCtD
Bosentan—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000423	0.00181	CcSEcCtD
Bosentan—Pollakiuria—Doxorubicin—liver cancer	0.00042	0.0018	CcSEcCtD
Bosentan—Haematuria—Epirubicin—liver cancer	0.000418	0.00179	CcSEcCtD
Bosentan—Hepatobiliary disease—Epirubicin—liver cancer	0.000414	0.00178	CcSEcCtD
Bosentan—Weight increased—Doxorubicin—liver cancer	0.000414	0.00178	CcSEcCtD
Bosentan—Epistaxis—Epirubicin—liver cancer	0.000413	0.00177	CcSEcCtD
Bosentan—Weight decreased—Doxorubicin—liver cancer	0.000411	0.00177	CcSEcCtD
Bosentan—Sinusitis—Epirubicin—liver cancer	0.000411	0.00176	CcSEcCtD
Bosentan—Hyperglycaemia—Doxorubicin—liver cancer	0.00041	0.00176	CcSEcCtD
Bosentan—Pneumonia—Doxorubicin—liver cancer	0.000408	0.00175	CcSEcCtD
Bosentan—Infestation NOS—Doxorubicin—liver cancer	0.000406	0.00174	CcSEcCtD
Bosentan—Infestation—Doxorubicin—liver cancer	0.000406	0.00174	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000402	0.00173	CcSEcCtD
Bosentan—Bradycardia—Epirubicin—liver cancer	0.000401	0.00172	CcSEcCtD
Bosentan—Renal failure—Doxorubicin—liver cancer	0.000399	0.00171	CcSEcCtD
Bosentan—Haemoglobin—Epirubicin—liver cancer	0.000395	0.0017	CcSEcCtD
Bosentan—Stomatitis—Doxorubicin—liver cancer	0.000395	0.0017	CcSEcCtD
Bosentan—Jaundice—Doxorubicin—liver cancer	0.000395	0.0017	CcSEcCtD
Bosentan—Conjunctivitis—Doxorubicin—liver cancer	0.000394	0.00169	CcSEcCtD
Bosentan—Urinary tract infection—Doxorubicin—liver cancer	0.000394	0.00169	CcSEcCtD
Bosentan—Haemorrhage—Epirubicin—liver cancer	0.000393	0.00169	CcSEcCtD
Bosentan—Hepatitis—Epirubicin—liver cancer	0.000393	0.00169	CcSEcCtD
Bosentan—Hypoaesthesia—Epirubicin—liver cancer	0.000391	0.00168	CcSEcCtD
Bosentan—Urinary tract disorder—Epirubicin—liver cancer	0.000389	0.00167	CcSEcCtD
Bosentan—Oedema peripheral—Epirubicin—liver cancer	0.000388	0.00166	CcSEcCtD
Bosentan—Haematuria—Doxorubicin—liver cancer	0.000387	0.00166	CcSEcCtD
Bosentan—Urethral disorder—Epirubicin—liver cancer	0.000386	0.00166	CcSEcCtD
Bosentan—Hepatobiliary disease—Doxorubicin—liver cancer	0.000384	0.00165	CcSEcCtD
Bosentan—Epistaxis—Doxorubicin—liver cancer	0.000382	0.00164	CcSEcCtD
Bosentan—Sinusitis—Doxorubicin—liver cancer	0.00038	0.00163	CcSEcCtD
Bosentan—Erythema multiforme—Epirubicin—liver cancer	0.000372	0.0016	CcSEcCtD
Bosentan—Bradycardia—Doxorubicin—liver cancer	0.000371	0.00159	CcSEcCtD
Bosentan—Eye disorder—Epirubicin—liver cancer	0.000368	0.00158	CcSEcCtD
Bosentan—Tinnitus—Epirubicin—liver cancer	0.000367	0.00157	CcSEcCtD
Bosentan—Haemoglobin—Doxorubicin—liver cancer	0.000366	0.00157	CcSEcCtD
Bosentan—Cardiac disorder—Epirubicin—liver cancer	0.000365	0.00157	CcSEcCtD
Bosentan—Flushing—Epirubicin—liver cancer	0.000365	0.00157	CcSEcCtD
Bosentan—Haemorrhage—Doxorubicin—liver cancer	0.000364	0.00156	CcSEcCtD
Bosentan—Hepatitis—Doxorubicin—liver cancer	0.000364	0.00156	CcSEcCtD
Bosentan—Hypoaesthesia—Doxorubicin—liver cancer	0.000362	0.00155	CcSEcCtD
Bosentan—Urinary tract disorder—Doxorubicin—liver cancer	0.000359	0.00154	CcSEcCtD
Bosentan—Oedema peripheral—Doxorubicin—liver cancer	0.000359	0.00154	CcSEcCtD
Bosentan—Angiopathy—Epirubicin—liver cancer	0.000357	0.00153	CcSEcCtD
Bosentan—Urethral disorder—Doxorubicin—liver cancer	0.000357	0.00153	CcSEcCtD
Bosentan—Immune system disorder—Epirubicin—liver cancer	0.000355	0.00153	CcSEcCtD
Bosentan—Mediastinal disorder—Epirubicin—liver cancer	0.000355	0.00152	CcSEcCtD
Bosentan—Chills—Epirubicin—liver cancer	0.000353	0.00152	CcSEcCtD
Bosentan—Mental disorder—Epirubicin—liver cancer	0.000345	0.00148	CcSEcCtD
Bosentan—Erythema multiforme—Doxorubicin—liver cancer	0.000344	0.00148	CcSEcCtD
Bosentan—Malnutrition—Epirubicin—liver cancer	0.000342	0.00147	CcSEcCtD
Bosentan—Erythema—Epirubicin—liver cancer	0.000342	0.00147	CcSEcCtD
Bosentan—Eye disorder—Doxorubicin—liver cancer	0.00034	0.00146	CcSEcCtD
Bosentan—Tinnitus—Doxorubicin—liver cancer	0.000339	0.00146	CcSEcCtD
Bosentan—Cardiac disorder—Doxorubicin—liver cancer	0.000338	0.00145	CcSEcCtD
Bosentan—Flushing—Doxorubicin—liver cancer	0.000338	0.00145	CcSEcCtD
Bosentan—Flatulence—Epirubicin—liver cancer	0.000337	0.00145	CcSEcCtD
Bosentan—Back pain—Epirubicin—liver cancer	0.000331	0.00142	CcSEcCtD
Bosentan—Angiopathy—Doxorubicin—liver cancer	0.00033	0.00142	CcSEcCtD
Bosentan—Muscle spasms—Epirubicin—liver cancer	0.000329	0.00141	CcSEcCtD
Bosentan—Immune system disorder—Doxorubicin—liver cancer	0.000329	0.00141	CcSEcCtD
Bosentan—Mediastinal disorder—Doxorubicin—liver cancer	0.000328	0.00141	CcSEcCtD
Bosentan—Chills—Doxorubicin—liver cancer	0.000327	0.0014	CcSEcCtD
Bosentan—Vision blurred—Epirubicin—liver cancer	0.000323	0.00139	CcSEcCtD
Bosentan—Mental disorder—Doxorubicin—liver cancer	0.000319	0.00137	CcSEcCtD
Bosentan—Erythema—Doxorubicin—liver cancer	0.000317	0.00136	CcSEcCtD
Bosentan—Malnutrition—Doxorubicin—liver cancer	0.000317	0.00136	CcSEcCtD
Bosentan—Anaemia—Epirubicin—liver cancer	0.000317	0.00136	CcSEcCtD
Bosentan—Flatulence—Doxorubicin—liver cancer	0.000312	0.00134	CcSEcCtD
Bosentan—Vertigo—Epirubicin—liver cancer	0.000308	0.00132	CcSEcCtD
Bosentan—Syncope—Epirubicin—liver cancer	0.000307	0.00132	CcSEcCtD
Bosentan—Leukopenia—Epirubicin—liver cancer	0.000307	0.00132	CcSEcCtD
Bosentan—Back pain—Doxorubicin—liver cancer	0.000307	0.00132	CcSEcCtD
Bosentan—Muscle spasms—Doxorubicin—liver cancer	0.000305	0.00131	CcSEcCtD
Bosentan—Palpitations—Epirubicin—liver cancer	0.000303	0.0013	CcSEcCtD
Bosentan—Loss of consciousness—Epirubicin—liver cancer	0.000301	0.00129	CcSEcCtD
Bosentan—Cough—Epirubicin—liver cancer	0.000299	0.00128	CcSEcCtD
Bosentan—Vision blurred—Doxorubicin—liver cancer	0.000299	0.00128	CcSEcCtD
Bosentan—Anaemia—Doxorubicin—liver cancer	0.000293	0.00126	CcSEcCtD
Bosentan—Chest pain—Epirubicin—liver cancer	0.000292	0.00125	CcSEcCtD
Bosentan—Arthralgia—Epirubicin—liver cancer	0.000292	0.00125	CcSEcCtD
Bosentan—Anxiety—Epirubicin—liver cancer	0.000291	0.00125	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00029	0.00124	CcSEcCtD
Bosentan—Discomfort—Epirubicin—liver cancer	0.000288	0.00124	CcSEcCtD
Bosentan—Dry mouth—Epirubicin—liver cancer	0.000285	0.00122	CcSEcCtD
Bosentan—Vertigo—Doxorubicin—liver cancer	0.000285	0.00122	CcSEcCtD
Bosentan—Syncope—Doxorubicin—liver cancer	0.000284	0.00122	CcSEcCtD
Bosentan—Leukopenia—Doxorubicin—liver cancer	0.000284	0.00122	CcSEcCtD
Bosentan—Palpitations—Doxorubicin—liver cancer	0.00028	0.0012	CcSEcCtD
Bosentan—Oedema—Epirubicin—liver cancer	0.00028	0.0012	CcSEcCtD
Bosentan—Anaphylactic shock—Epirubicin—liver cancer	0.00028	0.0012	CcSEcCtD
Bosentan—Loss of consciousness—Doxorubicin—liver cancer	0.000279	0.0012	CcSEcCtD
Bosentan—Infection—Epirubicin—liver cancer	0.000278	0.00119	CcSEcCtD
Bosentan—Cough—Doxorubicin—liver cancer	0.000277	0.00119	CcSEcCtD
Bosentan—Shock—Epirubicin—liver cancer	0.000275	0.00118	CcSEcCtD
Bosentan—Nervous system disorder—Epirubicin—liver cancer	0.000274	0.00118	CcSEcCtD
Bosentan—Thrombocytopenia—Epirubicin—liver cancer	0.000274	0.00117	CcSEcCtD
Bosentan—Tachycardia—Epirubicin—liver cancer	0.000273	0.00117	CcSEcCtD
Bosentan—Skin disorder—Epirubicin—liver cancer	0.000271	0.00117	CcSEcCtD
Bosentan—Hyperhidrosis—Epirubicin—liver cancer	0.00027	0.00116	CcSEcCtD
Bosentan—Chest pain—Doxorubicin—liver cancer	0.00027	0.00116	CcSEcCtD
Bosentan—Arthralgia—Doxorubicin—liver cancer	0.00027	0.00116	CcSEcCtD
Bosentan—Anxiety—Doxorubicin—liver cancer	0.000269	0.00115	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000268	0.00115	CcSEcCtD
Bosentan—Discomfort—Doxorubicin—liver cancer	0.000267	0.00114	CcSEcCtD
Bosentan—Anorexia—Epirubicin—liver cancer	0.000266	0.00114	CcSEcCtD
Bosentan—Dry mouth—Doxorubicin—liver cancer	0.000264	0.00113	CcSEcCtD
Bosentan—Hypotension—Epirubicin—liver cancer	0.000261	0.00112	CcSEcCtD
Bosentan—Oedema—Doxorubicin—liver cancer	0.000259	0.00111	CcSEcCtD
Bosentan—Anaphylactic shock—Doxorubicin—liver cancer	0.000259	0.00111	CcSEcCtD
Bosentan—Infection—Doxorubicin—liver cancer	0.000257	0.0011	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000255	0.00109	CcSEcCtD
Bosentan—Shock—Doxorubicin—liver cancer	0.000254	0.00109	CcSEcCtD
Bosentan—Nervous system disorder—Doxorubicin—liver cancer	0.000254	0.00109	CcSEcCtD
Bosentan—Thrombocytopenia—Doxorubicin—liver cancer	0.000253	0.00109	CcSEcCtD
Bosentan—Insomnia—Epirubicin—liver cancer	0.000253	0.00108	CcSEcCtD
Bosentan—Tachycardia—Doxorubicin—liver cancer	0.000252	0.00108	CcSEcCtD
Bosentan—Skin disorder—Doxorubicin—liver cancer	0.000251	0.00108	CcSEcCtD
Bosentan—Paraesthesia—Epirubicin—liver cancer	0.000251	0.00108	CcSEcCtD
Bosentan—Hyperhidrosis—Doxorubicin—liver cancer	0.00025	0.00107	CcSEcCtD
Bosentan—Dyspnoea—Epirubicin—liver cancer	0.000249	0.00107	CcSEcCtD
Bosentan—Somnolence—Epirubicin—liver cancer	0.000248	0.00107	CcSEcCtD
Bosentan—Anorexia—Doxorubicin—liver cancer	0.000247	0.00106	CcSEcCtD
Bosentan—Dyspepsia—Epirubicin—liver cancer	0.000246	0.00106	CcSEcCtD
Bosentan—Decreased appetite—Epirubicin—liver cancer	0.000243	0.00104	CcSEcCtD
Bosentan—Hypotension—Doxorubicin—liver cancer	0.000242	0.00104	CcSEcCtD
Bosentan—Gastrointestinal disorder—Epirubicin—liver cancer	0.000241	0.00104	CcSEcCtD
Bosentan—Fatigue—Epirubicin—liver cancer	0.000241	0.00103	CcSEcCtD
Bosentan—Pain—Epirubicin—liver cancer	0.000239	0.00103	CcSEcCtD
Bosentan—Constipation—Epirubicin—liver cancer	0.000239	0.00103	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000236	0.00101	CcSEcCtD
Bosentan—Insomnia—Doxorubicin—liver cancer	0.000234	0.001	CcSEcCtD
Bosentan—Paraesthesia—Doxorubicin—liver cancer	0.000232	0.000997	CcSEcCtD
Bosentan—Dyspnoea—Doxorubicin—liver cancer	0.000231	0.00099	CcSEcCtD
Bosentan—Somnolence—Doxorubicin—liver cancer	0.00023	0.000987	CcSEcCtD
Bosentan—Gastrointestinal pain—Epirubicin—liver cancer	0.000229	0.000981	CcSEcCtD
Bosentan—Dyspepsia—Doxorubicin—liver cancer	0.000228	0.000977	CcSEcCtD
Bosentan—Decreased appetite—Doxorubicin—liver cancer	0.000225	0.000965	CcSEcCtD
Bosentan—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000223	0.000958	CcSEcCtD
Bosentan—Fatigue—Doxorubicin—liver cancer	0.000223	0.000957	CcSEcCtD
Bosentan—Urticaria—Epirubicin—liver cancer	0.000222	0.000953	CcSEcCtD
Bosentan—Constipation—Doxorubicin—liver cancer	0.000221	0.000949	CcSEcCtD
Bosentan—Pain—Doxorubicin—liver cancer	0.000221	0.000949	CcSEcCtD
Bosentan—Abdominal pain—Epirubicin—liver cancer	0.000221	0.000948	CcSEcCtD
Bosentan—Body temperature increased—Epirubicin—liver cancer	0.000221	0.000948	CcSEcCtD
Bosentan—Gastrointestinal pain—Doxorubicin—liver cancer	0.000211	0.000908	CcSEcCtD
Bosentan—Hypersensitivity—Epirubicin—liver cancer	0.000206	0.000884	CcSEcCtD
Bosentan—Urticaria—Doxorubicin—liver cancer	0.000205	0.000882	CcSEcCtD
Bosentan—Abdominal pain—Doxorubicin—liver cancer	0.000204	0.000877	CcSEcCtD
Bosentan—Body temperature increased—Doxorubicin—liver cancer	0.000204	0.000877	CcSEcCtD
Bosentan—Asthenia—Epirubicin—liver cancer	0.000201	0.000861	CcSEcCtD
Bosentan—Pruritus—Epirubicin—liver cancer	0.000198	0.000849	CcSEcCtD
Bosentan—Diarrhoea—Epirubicin—liver cancer	0.000191	0.000821	CcSEcCtD
Bosentan—Hypersensitivity—Doxorubicin—liver cancer	0.000191	0.000818	CcSEcCtD
Bosentan—Asthenia—Doxorubicin—liver cancer	0.000186	0.000796	CcSEcCtD
Bosentan—Dizziness—Epirubicin—liver cancer	0.000185	0.000793	CcSEcCtD
Bosentan—Pruritus—Doxorubicin—liver cancer	0.000183	0.000785	CcSEcCtD
Bosentan—Vomiting—Epirubicin—liver cancer	0.000178	0.000763	CcSEcCtD
Bosentan—Diarrhoea—Doxorubicin—liver cancer	0.000177	0.000759	CcSEcCtD
Bosentan—Rash—Epirubicin—liver cancer	0.000176	0.000756	CcSEcCtD
Bosentan—Dermatitis—Epirubicin—liver cancer	0.000176	0.000756	CcSEcCtD
Bosentan—Headache—Epirubicin—liver cancer	0.000175	0.000752	CcSEcCtD
Bosentan—Dizziness—Doxorubicin—liver cancer	0.000171	0.000734	CcSEcCtD
Bosentan—Nausea—Epirubicin—liver cancer	0.000166	0.000713	CcSEcCtD
Bosentan—Vomiting—Doxorubicin—liver cancer	0.000164	0.000706	CcSEcCtD
Bosentan—Rash—Doxorubicin—liver cancer	0.000163	0.0007	CcSEcCtD
Bosentan—Dermatitis—Doxorubicin—liver cancer	0.000163	0.000699	CcSEcCtD
Bosentan—Headache—Doxorubicin—liver cancer	0.000162	0.000695	CcSEcCtD
Bosentan—Nausea—Doxorubicin—liver cancer	0.000154	0.000659	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.000127	0.000678	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NR1H4—liver cancer	0.000126	0.000674	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CSF2—liver cancer	0.000124	0.000665	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—F2—liver cancer	0.000124	0.000663	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTA3—liver cancer	0.000124	0.000663	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GGT1—liver cancer	0.000123	0.000658	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.000121	0.000649	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000119	0.000639	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PIK3CG—liver cancer	0.000118	0.000634	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PIK3CD—liver cancer	0.000115	0.000614	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000114	0.000608	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTA4—liver cancer	0.000113	0.000606	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CSF2—liver cancer	0.000113	0.000604	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000111	0.000592	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTP1—liver cancer	0.00011	0.000591	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTA2—liver cancer	0.00011	0.000591	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	0.000109	0.000583	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000108	0.00058	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTA1—liver cancer	0.000106	0.00057	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PRKCE—liver cancer	0.000105	0.000564	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NAT2—liver cancer	0.000105	0.000563	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PIK3CD—liver cancer	0.000104	0.000557	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADAM17—liver cancer	0.000103	0.000554	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTM1—liver cancer	0.000101	0.000543	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000101	0.000542	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALDOB—liver cancer	0.000101	0.00054	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	0.0001	0.000536	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PIK3CB—liver cancer	9.99e-05	0.000535	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IGF2—liver cancer	9.97e-05	0.000534	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	9.78e-05	0.000524	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—F2—liver cancer	9.75e-05	0.000522	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PSMA4—liver cancer	9.73e-05	0.000521	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PSMD10—liver cancer	9.73e-05	0.000521	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CRABP1—liver cancer	9.62e-05	0.000515	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—CYP1A1—liver cancer	9.62e-05	0.000515	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	9.48e-05	0.000508	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	9.43e-05	0.000505	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CG—liver cancer	9.33e-05	0.0005	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CSF2—liver cancer	9.31e-05	0.000499	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—RAF1—liver cancer	9.29e-05	0.000498	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—H2AFX—liver cancer	9.18e-05	0.000492	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—IL2—liver cancer	9.18e-05	0.000491	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PIK3CB—liver cancer	9.07e-05	0.000486	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—F2—liver cancer	8.86e-05	0.000474	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP2E1—liver cancer	8.83e-05	0.000473	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	8.71e-05	0.000466	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.66e-05	0.000464	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CG—liver cancer	8.47e-05	0.000454	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HPGDS—liver cancer	8.41e-05	0.00045	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.36e-05	0.000448	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL2—liver cancer	8.33e-05	0.000446	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TERT—liver cancer	8.3e-05	0.000445	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CD—liver cancer	8.2e-05	0.000439	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GGT1—liver cancer	8.1e-05	0.000434	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.62e-05	0.000408	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—KDR—liver cancer	7.59e-05	0.000407	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK14—liver cancer	7.54e-05	0.000404	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PRKCE—liver cancer	7.54e-05	0.000404	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.52e-05	0.000403	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PSMD10—liver cancer	7.5e-05	0.000401	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PSMA4—liver cancer	7.5e-05	0.000401	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CD—liver cancer	7.45e-05	0.000399	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ESR1—liver cancer	7.4e-05	0.000396	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—F2—liver cancer	7.31e-05	0.000391	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GOT2—liver cancer	7.29e-05	0.00039	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTP1—liver cancer	7.28e-05	0.00039	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	7.21e-05	0.000386	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—UGDH—liver cancer	7.19e-05	0.000385	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	7.18e-05	0.000384	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CB—liver cancer	7.15e-05	0.000383	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IGF2—liver cancer	7.14e-05	0.000382	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CG—liver cancer	6.99e-05	0.000375	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APC—liver cancer	6.99e-05	0.000375	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP2E1—liver cancer	6.86e-05	0.000367	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—EPT1—liver cancer	6.76e-05	0.000362	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTM1—liver cancer	6.69e-05	0.000358	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CSF2—liver cancer	6.67e-05	0.000357	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—RAF1—liver cancer	6.65e-05	0.000356	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.64e-05	0.000355	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	6.6e-05	0.000353	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—BRAF—liver cancer	6.57e-05	0.000352	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—H2AFX—liver cancer	6.57e-05	0.000352	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2—liver cancer	6.57e-05	0.000352	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CB—liver cancer	6.49e-05	0.000348	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYCS—liver cancer	6.41e-05	0.000344	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TAT—liver cancer	6.41e-05	0.000343	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP1A1—liver cancer	6.34e-05	0.00034	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	6.3e-05	0.000338	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GOT1—liver cancer	6.29e-05	0.000337	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GGT1—liver cancer	6.29e-05	0.000337	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	6.25e-05	0.000335	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CD—liver cancer	6.15e-05	0.000329	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PIK3CA—liver cancer	6.09e-05	0.000326	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SERPINE1—liver cancer	6.08e-05	0.000326	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—KRAS—liver cancer	6.02e-05	0.000322	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2—liver cancer	5.96e-05	0.000319	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TERT—liver cancer	5.94e-05	0.000318	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTP1—liver cancer	5.65e-05	0.000303	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HMOX1—liver cancer	5.58e-05	0.000299	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PIK3CA—liver cancer	5.53e-05	0.000296	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RAF1—liver cancer	5.49e-05	0.000294	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KDR—liver cancer	5.43e-05	0.000291	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK14—liver cancer	5.4e-05	0.000289	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MTOR—liver cancer	5.36e-05	0.000287	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CB—liver cancer	5.36e-05	0.000287	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ESR1—liver cancer	5.3e-05	0.000284	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—F2—liver cancer	5.23e-05	0.00028	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTM1—liver cancer	5.2e-05	0.000278	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—HRAS—liver cancer	5.12e-05	0.000274	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDKN1B—liver cancer	5.03e-05	0.000269	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APC—liver cancer	5.01e-05	0.000268	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CG—liver cancer	5.01e-05	0.000268	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AKT1—liver cancer	4.98e-05	0.000266	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CASP3—liver cancer	4.93e-05	0.000264	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP1A1—liver cancer	4.93e-05	0.000264	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2—liver cancer	4.92e-05	0.000264	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—liver cancer	4.9e-05	0.000262	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCND1—liver cancer	4.8e-05	0.000257	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—JUN—liver cancer	4.79e-05	0.000256	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CTNNB1—liver cancer	4.75e-05	0.000254	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—UGDH—liver cancer	4.74e-05	0.000254	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.72e-05	0.000253	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—BRAF—liver cancer	4.71e-05	0.000252	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—liver cancer	4.66e-05	0.000249	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDKN1A—liver cancer	4.64e-05	0.000249	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MTHFR—liver cancer	4.59e-05	0.000246	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK8—liver cancer	4.53e-05	0.000243	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AKT1—liver cancer	4.52e-05	0.000242	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARA—liver cancer	4.5e-05	0.000241	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—EPT1—liver cancer	4.46e-05	0.000239	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CD—liver cancer	4.4e-05	0.000236	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CA—liver cancer	4.36e-05	0.000233	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GLUL—liver cancer	4.36e-05	0.000233	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CPT1B—liver cancer	4.36e-05	0.000233	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SERPINE1—liver cancer	4.35e-05	0.000233	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—KRAS—liver cancer	4.31e-05	0.000231	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TAT—liver cancer	4.23e-05	0.000226	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NR1H4—liver cancer	4.2e-05	0.000225	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—liver cancer	4.18e-05	0.000224	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—STAT3—liver cancer	4.14e-05	0.000222	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTA3—liver cancer	4.13e-05	0.000221	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.05e-05	0.000217	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CA—liver cancer	3.96e-05	0.000212	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RAF1—liver cancer	3.93e-05	0.00021	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CG—liver cancer	3.86e-05	0.000207	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MYC—liver cancer	3.85e-05	0.000206	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TGFB1—liver cancer	3.84e-05	0.000206	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MTOR—liver cancer	3.84e-05	0.000205	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CB—liver cancer	3.84e-05	0.000205	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTA4—liver cancer	3.78e-05	0.000202	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARG—liver cancer	3.72e-05	0.000199	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.69e-05	0.000198	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTA2—liver cancer	3.68e-05	0.000197	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—HRAS—liver cancer	3.66e-05	0.000196	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN1B—liver cancer	3.6e-05	0.000193	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AKT1—liver cancer	3.56e-05	0.000191	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—KRAS—liver cancer	3.56e-05	0.00019	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTA1—liver cancer	3.55e-05	0.00019	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CASP3—liver cancer	3.53e-05	0.000189	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2—liver cancer	3.52e-05	0.000189	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NAT2—liver cancer	3.51e-05	0.000188	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—liver cancer	3.51e-05	0.000188	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCND1—liver cancer	3.43e-05	0.000184	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—JUN—liver cancer	3.43e-05	0.000184	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CTNNB1—liver cancer	3.4e-05	0.000182	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CD—liver cancer	3.39e-05	0.000182	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.38e-05	0.000181	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALDOB—liver cancer	3.37e-05	0.00018	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—liver cancer	3.35e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—liver cancer	3.33e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDKN1A—liver cancer	3.32e-05	0.000178	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CA—liver cancer	3.27e-05	0.000175	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK8—liver cancer	3.24e-05	0.000174	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AKT1—liver cancer	3.23e-05	0.000173	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CRABP1—liver cancer	3.21e-05	0.000172	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TP53—liver cancer	3.16e-05	0.000169	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HRAS—liver cancer	3.02e-05	0.000162	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—liver cancer	2.99e-05	0.00016	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—STAT3—liver cancer	2.96e-05	0.000159	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CB—liver cancer	2.96e-05	0.000158	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—liver cancer	2.89e-05	0.000155	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.89e-05	0.000155	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GLUL—liver cancer	2.87e-05	0.000154	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CPT1B—liver cancer	2.87e-05	0.000154	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HPGDS—liver cancer	2.81e-05	0.00015	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.79e-05	0.000149	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NR1H4—liver cancer	2.77e-05	0.000148	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MYC—liver cancer	2.75e-05	0.000148	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TGFB1—liver cancer	2.75e-05	0.000147	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTA3—liver cancer	2.72e-05	0.000146	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AKT1—liver cancer	2.67e-05	0.000143	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KRAS—liver cancer	2.55e-05	0.000136	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.54e-05	0.000136	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.51e-05	0.000134	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PSMA4—liver cancer	2.5e-05	0.000134	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PSMD10—liver cancer	2.5e-05	0.000134	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTA4—liver cancer	2.49e-05	0.000133	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GOT2—liver cancer	2.43e-05	0.00013	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTA2—liver cancer	2.43e-05	0.00013	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTA1—liver cancer	2.34e-05	0.000125	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CA—liver cancer	2.34e-05	0.000125	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NAT2—liver cancer	2.32e-05	0.000124	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2E1—liver cancer	2.29e-05	0.000123	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TP53—liver cancer	2.26e-05	0.000121	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDOB—liver cancer	2.22e-05	0.000119	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.22e-05	0.000119	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HRAS—liver cancer	2.16e-05	0.000116	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYCS—liver cancer	2.14e-05	0.000115	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CRABP1—liver cancer	2.12e-05	0.000113	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GGT1—liver cancer	2.1e-05	0.000113	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GOT1—liver cancer	2.1e-05	0.000113	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—liver cancer	2.07e-05	0.000111	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT1—liver cancer	1.91e-05	0.000102	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTP1—liver cancer	1.89e-05	0.000101	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMOX1—liver cancer	1.86e-05	9.97e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HPGDS—liver cancer	1.85e-05	9.92e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CA—liver cancer	1.8e-05	9.65e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTM1—liver cancer	1.73e-05	9.29e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PSMA4—liver cancer	1.65e-05	8.84e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PSMD10—liver cancer	1.65e-05	8.84e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP1A1—liver cancer	1.64e-05	8.81e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GOT2—liver cancer	1.61e-05	8.6e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MTHFR—liver cancer	1.53e-05	8.21e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2E1—liver cancer	1.51e-05	8.08e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARA—liver cancer	1.5e-05	8.05e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AKT1—liver cancer	1.47e-05	7.88e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYCS—liver cancer	1.41e-05	7.56e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GGT1—liver cancer	1.39e-05	7.42e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GOT1—liver cancer	1.39e-05	7.42e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.35e-05	7.23e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CG—liver cancer	1.29e-05	6.9e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTP1—liver cancer	1.24e-05	6.67e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARG—liver cancer	1.24e-05	6.66e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMOX1—liver cancer	1.23e-05	6.57e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTM1—liver cancer	1.14e-05	6.13e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CD—liver cancer	1.13e-05	6.06e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—liver cancer	1.12e-05	5.99e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP1A1—liver cancer	1.08e-05	5.81e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MTHFR—liver cancer	1.01e-05	5.41e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARA—liver cancer	9.92e-06	5.31e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CB—liver cancer	9.87e-06	5.29e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CG—liver cancer	8.49e-06	4.55e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARG—liver cancer	8.2e-06	4.39e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CD—liver cancer	7.47e-06	4e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—liver cancer	7.37e-06	3.95e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CB—liver cancer	6.51e-06	3.49e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CA—liver cancer	6.02e-06	3.22e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKT1—liver cancer	4.91e-06	2.63e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CA—liver cancer	3.97e-06	2.12e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKT1—liver cancer	3.24e-06	1.74e-05	CbGpPWpGaD
